Clinical Trial Detail

NCT ID NCT04173338
Title Cabozantinib With Pemetrexed in Advanced Non-small Cell Lung Cancer, Urothelial Cancer and Malignant Mesothelioma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Augusta University
Indications

lung non-small cell carcinoma

transitional cell carcinoma

malignant mesothelioma

Therapies

Cabozantinib + Pemetrexed Disodium

Age Groups: adult senior

No variant requirements are available.